Philadelphia, Pennsylvania--(Newsfile Corp. - October 4, 2024) - Grabar Law Office is investigating claims on behalf of DocGo Inc. (NASDAQ: DCGO) shareholders. The investigation concerns whether certain officers and directors of DocGo have breached their fiduciary duties owed to the company as, on April 10th the New York City Mayor's office said that the mobile health services provider's $432M no-bid migrant services contract will not be renewed before it expires on May 5. Instead, the officials plan to issue a competitive request to select a new provider by year-end.
Current DocGo Inc. (NASDAQ: DCGO) shareholders who have held DocGo shares since on or before November 8, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. To learn more visit: https://grabarlaw.com/the-latest/docgo-shareholder-investigation/.
An underlying securities fraud class action complaint was filed after the New York City's Comptroller announced that it was commencing a real-time audit of operations and invoices incurred by DocGo as the Comptroller had "serious concerns about the selection of this vendor and its performance of contract duties." The motion to dismiss that complaint is now fully briefed.
On April 10, 2024, The New York City Mayor's office announced that the mobile health services provider's $432M no-bid migrant services contract will not be renewed before it expires on May 5. Instead, the officials plan to issue a competitive request to select a new provider by year-end.
DocGo share prices are down approximately 70% from previous trading highs.
If you would like to learn more about this matter, you are encouraged visit https://grabarlaw.com/the-latest/docgo-shareholder-investigation/, email Joshua Grabar at jgrabar@grabarlaw.com or Mia Heller at mheller@grabarlaw.com, or call us at 267-507-6085.
$DCGO #DocGo
Attorney Advertising Disclaimer
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/225572
